SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 25.77 |
Enterprise Value ($M) | 15.60 |
Book Value ($M) | 28.05 |
Book Value / Share | 2.45 |
Price / Book | 0.92 |
NCAV ($M) | -5.00 |
NCAV / Share | -0.44 |
Price / NCAV | -5.15 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | 1.88 |
Return on Assets (ROA) | 0.76 |
Return on Equity (ROE) | 1.94 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 1.20 |
Current Ratio | 1.20 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 17.44 |
Assets | 50.49 |
Liabilities | 22.44 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | 0.00 |
Net Income | 0.00 |
Earnings Per Share Basic And Diluted | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 0.00 |
Cash from Investing | 0.00 |
Cash from Financing | 0.00 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13D/A | Rubric Capital Management LP | 25.73 | 42.38 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
2,646 | 12,312 | 21.49 | |
2,971 | 9,292 | 31.97 | |
2,349 | 14,177 | 16.57 | |
9,407 | 36,752 | 25.60 | |
(click for more detail) |
Similar Companies | |
---|---|
TSHA – Taysha Gene Therapies, Inc. | TSVT – 2seventy bio, Inc. |
TWST – Twist Bioscience Corporation | TYRA – Tyra Biosciences, Inc. |
UBX – Unity Biotechnology, Inc. |